Sublingual Tablet Articles & Analysis
1 news found
The granted R&D project is 'Development of sublingual COVID-19 subunit vaccine,' in which CHA Vaccine Institute, PanGen Biotech, and BioLingus will develop a sublingual tablet or drop type of recombinant subunit COVID-19 vaccine. Sublingual vaccines as a tablet type are dissolved under the tongue and absorbed ...